Literature DB >> 3178487

Cachectin/TNF production in experimental burns and Pseudomonas infection.

M A Marano1, L L Moldawer, Y Fong, H Wei, J Minei, R Yurt, A Cerami, S F Lowry.   

Abstract

Burn injury and infection result in significant losses of lean tissue. The cytokine cachectin/tumor necrosis factor has been implicated in this process but is not uniformly detected during infection. We sought to determine the relationship between body composition changes and in vivo hepatic levels of pretranslational message for cachectin (messenger RNA) in a burn and infection rodent model. Adult Wistar rats were grouped as follows: (1) freely fed, (2) 30% burn, (3) 30% burn with Pseudomonas aeruginosa infection, (4) pair fed, and (5) 30% burn and infection with recombinant cachectin. Compared with controls or animals only burned, burned and infected rats had a 100% increase in hepatic cachectin messenger RNA content, lost carcass protein, and exhibited muscle loss with sparing of liver mass. Tissue production of cachectin as well as other cytokines may be sufficient to mediate several body composition changes observed in response to injury and infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3178487     DOI: 10.1001/archsurg.1988.01400350097015

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  16 in total

Review 1.  The role of mediators in the response to thermal injury.

Authors:  Y K Youn; C LaLonde; R Demling
Journal:  World J Surg       Date:  1992 Jan-Feb       Impact factor: 3.352

2.  Bacterial translocation and intestinal atrophy after thermal injury and burn wound sepsis.

Authors:  W G Jones; J P Minei; A E Barber; J L Rayburn; T J Fahey; G T Shires; G T Shires
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

Review 3.  TNF-alpha and insulin resistance: summary and future prospects.

Authors:  P Peraldi; B Spiegelman
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

4.  Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.

Authors:  H R Alexander; B C Sheppard; J C Jensen; H N Langstein; C M Buresh; D Venzon; E C Walker; D L Fraker; M C Stovroff; J A Norton
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

5.  Tumor necrosis factor alpha inhibits signaling from the insulin receptor.

Authors:  G S Hotamisligil; D L Murray; L N Choy; B M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

6.  Proteomic analysis of altered protein expression in skeletal muscle of rats in a hypermetabolic state induced by burn sepsis.

Authors:  Xunbao Duan; François Berthiaume; David Yarmush; Martin L Yarmush
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

7.  Increased intestinal protein synthesis during sepsis and following the administration of tumour necrosis factor alpha or interleukin-1 alpha.

Authors:  D von Allmen; P O Hasselgren; T Higashiguchi; J Frederick; O Zamir; J E Fischer
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

8.  Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression.

Authors:  S H Zuckerman; G F Evans; L D Butler
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

9.  Production of tumor necrosis factor, interleukin-6 and prostaglandin E2 by LPS-stimulated rat bone marrow macrophages after thermal injury: effect of indomethacin.

Authors:  C K Ogle; X Guo; K Szczur; S Hartmann; J D Ogle
Journal:  Inflammation       Date:  1994-04       Impact factor: 4.092

Review 10.  Is there value in plasma cytokine measurements in patients with severe trauma and sepsis?

Authors:  Lori F Gentile; Alex G Cuenca; Erin L Vanzant; Philip A Efron; Bruce McKinley; Frederick Moore; Lyle L Moldawer
Journal:  Methods       Date:  2013-05-11       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.